What is Evolus's R&D?

Evolus (EOLS) reported R&D of $2.24M in Q1 2026.

How has Evolus's R&D changed year-over-year?

Evolus's R&D increased by 1.3% year-over-year, from $2.21M to $2.24M.

What is the long-term trend for Evolus's R&D?

Over 4 years (2021 to 2025), Evolus's R&D has grown at a 46.8% compound annual growth rate (CAGR), from $2.06M to $9.58M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Evolus EOLS R&D

R&D at other companies

BeldenBDC

$30.09M+5.9%

Cabot CorporationCBT

$14M-6.7%

Envista Holdings CorporationNVST

$30M+18.6%

VontierVNT

$41.4M+3.0%

Archer AviationACHR

$171.7M+65.6%

Kiniksa Pharmaceuticals International, plcKNSA

$27.48M+42.2%

Segments

By segment

See full

Reportable Segment$2.24M+1.3%

Other financials

Income statement

See full

Revenue$73.1M+6.7%

Gross profit$48.9M+4.8%

Operating income-$6.8M+54.9%

Net income-$10.7M+43.5%

EPS (diluted)-$0.16+46.7%

Balance sheet

See full

Cash & equivalents$49.8M-26.7%

Total debt$164.9M-4.1%

Total equity-$28.8M-336%

Total assets$220.6M+3.4%

Cash flow

See full

Operating cash flow-$10.0M+36.3%

CapEx$415.0K+30.1%

Free cash flow-$10.4M+35.0%

Valuation

See full

Market cap$470.86M-21.3%

Enterprise value$585.97M-16.6%

P/S1.6×-0.6×

Profitability

See full

Gross margin66.1%-2.4pp

Operating margin-13.7%-1.9pp

Net margin-14.4%-3.3pp

FCF margin-9.6%-3.6pp

Returns & leverage

See full

Return on equity-472.6%-1,534pp

Debt / equity22.2×—

Current ratio2×-0.3×

Where this comes from

Reported directly by Evolus in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.

The official record: Evolus’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolus's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evolus's R&D?: Evolus (EOLS) reported R&D of $2.24M in Q1 2026.
How has Evolus's R&D changed year-over-year?: Evolus's R&D increased by 1.3% year-over-year, from $2.21M to $2.24M.
What is the long-term trend for Evolus's R&D?: Over 4 years (2021 to 2025), Evolus's R&D has grown at a 46.8% compound annual growth rate (CAGR), from $2.06M to $9.58M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.